Latest Breaking News On - Good clinical - Page 3 : comparemela.com

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South africaUnited kingdomUnited statesNew yorkGreen light committee western pacific regional officeGlobal alliance against tuberculosisTb drug developmentFast clubEuropean developing countries clinical trials partnershipGlobal allianceLondon school of hygiene tropical medicineGlobal fund to fightDepartment of foreign affairsCritical path instituteResearch future fund of the australian governmentEu innovative medicines initiative

Clinical Trial Manager | VUFO - NGO Resource Centre Vietnam

Clinical Trial Manager | VUFO - NGO Resource Centre Vietnam
ngocentre.org.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ngocentre.org.vn Daily Mail and Mail on Sunday newspapers.

New south walesHo chi minh cityH chíinhRepublic ofUniversity of sydneyWoolcock instituteWoolcock institute of medical researchClinical trialClinical trials regionalExecutive directorMedical researchGood clinicalStandard operating proceduresCountry directorPrincipal investigatorsChief investigators

Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes

This study examines the efficacy and safety of tirzepatide vs insulin lispro adjunctive therapy to insulin glargine among those receiving basal insulin with ina

Eteläuomen läiUnited statesCzech republicEli lillyJulio rosenstockEuropean association for the study of diabetesScientific sessions of the american diabetes associationNovo nordiskBoehringer ingelheimVelocity clinical research at medical cityGood clinicalSize calculationSecondary outcomesExploratory end pointsVelocity clinical researchMedical city

Assessments Of Drug Safety And Effectiveness Continue To Fail People With Obesity

Assessments Of Drug Safety And Effectiveness Continue To Fail People With Obesity
healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.

Williamh dietzChristinar chowRobert califfPosaconazole noxafilGilbert burckartNutrition examinationNovo nordiskDrug administrationNational healthOffice of clinical pharmacologyObesity allianceCommissioner robert califfClinical pharmacologyNutrition examination surveyClinical trials guidance documentsRegulations relating

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial | Cardiology | JAMA

This phase 1 randomized clinical trial evaluates the safety, tolerability, pharmacokinetics, and exploratory pharmacodynamic biomarker effects of muvalaplin in

United statesNoord hollandSouth australiaEteläuomen läiLoredana spoerriEli lillyStephenj nichollsEsperion therapeutics incPharma groupBoehringer ingelheimAmsterdam pharmaceuticalsBristol myers squibbMonash universityVictorian heart instituteMedicines companyEuropean society of cardiology congress